| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/15/2014 | US8697359 CRISPR-Cas systems and methods for altering expression of gene products |
| 04/15/2014 | US8697348 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
| 04/15/2014 | US8697155 Treatment of obesity and related disorders |
| 04/15/2014 | US8697151 Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition |
| 04/15/2014 | US8697139 Method of intervertebral disc treatment using articular chondrocyte cells |
| 04/15/2014 | US8697133 Slow release compositions |
| 04/15/2014 | US8697107 Flowable implant with crosslinkable surface membrane |
| 04/15/2014 | US8697105 Injectable drug delivery formulation |
| 04/15/2014 | US8697099 Cosmetic treatment system and methods |
| 04/15/2014 | US8697084 HIV consensus envelope sequences and methods for using the same |
| 04/15/2014 | US8697083 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies |
| 04/15/2014 | US8697082 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 04/15/2014 | US8697077 Methods and compositions for treating autoimmune diseases |
| 04/15/2014 | US8697070 1D05 PCSK9 antagonists |
| 04/15/2014 | US8697069 Methods related to TIM 3, a Th1-specific cell surface molecule, for activating antigen presenting cells |
| 04/15/2014 | US8697066 Botulinum toxin compositions and methods |
| 04/15/2014 | US8697065 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/15/2014 | US8697063 Polypeptides having phytase activity and polynucleotides encoding same |
| 04/15/2014 | US8697062 Compositions and methods for ribonuclease-based therapeutics |
| 04/15/2014 | US8697061 Tumor specific oligosaccharide epitopes and use thereof |
| 04/15/2014 | US8697051 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/15/2014 | US8697050 Methods of treatment using a vector encoding p21/Cip1 |
| 04/15/2014 | US8697049 Modified bacteriophage including an alpha/beta small acid-soluble spore protein (SASP) gene |
| 04/15/2014 | US8697048 Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells |
| 04/15/2014 | US8697047 Stable immunogenic product comprising antigenic heterocomplexes |
| 04/15/2014 | US8697046 Methods of administering interferon gamma to absorb fluid from the subretinal space |
| 04/15/2014 | US8697045 Pegylated interleukin-10 |
| 04/15/2014 | US8697031 Dual function polymer micelles |
| 04/15/2014 | CA2764284C A system and method for providing closed loop infusion formulation delivery |
| 04/15/2014 | CA2702750C A novel strain of bacillus for controlling plant diseases and corn rootworm |
| 04/15/2014 | CA2630578C Orally absorbed pharmaceutical formulation and method of administration |
| 04/15/2014 | CA2600749C Dimeric or multimeric microproteins |
| 04/15/2014 | CA2566607C Use of lacritin in promoting ocular cell survival |
| 04/15/2014 | CA2565215C Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 04/15/2014 | CA2547899C Cell-based therapies for ischemia |
| 04/15/2014 | CA2502162C Fvii or fviia variants having increased clotting activity |
| 04/15/2014 | CA2495498C Use of cgrp antagonist compounds for treatment of psoriasis |
| 04/15/2014 | CA2399298C Use of il-18 inhibitors |
| 04/15/2014 | CA2383877C Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 04/15/2014 | CA2328414C Methods for detecting and inhibiting angiogenesis |
| 04/10/2014 | WO2014055986A1 Methods and compositions for expanding hematopoietic stem and progenitor cells |
| 04/10/2014 | WO2014055949A1 Platelet compositions and uses thereof |
| 04/10/2014 | WO2014055869A1 Treatment of cancer with alk1 antagonists |
| 04/10/2014 | WO2014055748A1 Modulation of immune function by dietary bovine lactoferrin |
| 04/10/2014 | WO2014055682A1 Immunomodulatory minicells and methods of use |
| 04/10/2014 | WO2014055672A1 Clay product and uses thereof |
| 04/10/2014 | WO2014055591A1 Angiotensin in treating brain conditions |
| 04/10/2014 | WO2014055564A1 Stabilized polypeptide insulin receptor modulators |
| 04/10/2014 | WO2014055515A1 Use of p3 of bacteriophage fusion proteins as amyloid binding agents |
| 04/10/2014 | WO2014055461A1 Iap antagonists |
| 04/10/2014 | WO2014055413A2 A method of providing cellular therapy using modified natural killer cells or t lymphocytes |
| 04/10/2014 | WO2014055253A1 Methods of synthesizing and using peg-like fluorochromes |
| 04/10/2014 | WO2014055127A1 Methods of inhibiting surface attachment of microorganisms |
| 04/10/2014 | WO2014055073A1 Antigens associated with inflammatory bowel disease |
| 04/10/2014 | WO2014055039A1 Peptides and methods for treating cancer |
| 04/10/2014 | WO2014054798A1 Drug for inhibiting malignant tumor metastasis |
| 04/10/2014 | WO2014054046A1 Ordered reversible fibrils, aggregates and multimers of proteins and uses thereof |
| 04/10/2014 | WO2014054004A1 Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour |
| 04/10/2014 | WO2014053999A1 Cxcl3 chemokine for the therapeutic treatment of medulloblastoma |
| 04/10/2014 | WO2014053873A1 Polymeric prodrug conjugates |
| 04/10/2014 | WO2014053871A1 A method for screening a compound capable of inhibiting the notch1 transcriptional activity |
| 04/10/2014 | WO2014053834A1 Cyclic depsipeptide compounds and their uses |
| 04/10/2014 | WO2014053651A1 Biotherapy for pain |
| 04/10/2014 | WO2014053596A1 A nod2-dependent pathway of cytoprotection of stem cells |
| 04/10/2014 | WO2014053533A1 Use of substituted 3-heteroaroylamino-propionic acid derivatives as pharmaceuticals for prevention/treatment of atrial fibrillation |
| 04/10/2014 | WO2014053481A1 Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza |
| 04/10/2014 | WO2014053223A1 Use of degarelix in the treatment of endometriosis and related diseases |
| 04/10/2014 | WO2014030125A3 Use of a casein hydrolysate as an antiherpetic agent |
| 04/10/2014 | WO2014026078A8 Attenuating or treating sepsis or septic shock |
| 04/10/2014 | WO2014023923A3 Treatment of osteoarthritis with incretin hormones or analogues thereof |
| 04/10/2014 | WO2014016613A3 Type b lantibiotic nvb302 for the treatment of c. difficile infection |
| 04/10/2014 | WO2013188824A3 Hexim-1 as a target of leptin signaling to regulate obesity and diabetes |
| 04/10/2014 | WO2013188016A3 Surfactant therapy for exposure to ionizing radiation |
| 04/10/2014 | WO2013184912A3 Binding agents that modulate the hippo pathway and uses thereof |
| 04/10/2014 | WO2013177444A3 Influenza vaccine constructs |
| 04/10/2014 | WO2013173512A3 High-transduction-efficiency raav vectors, compositions, and methods of use |
| 04/10/2014 | WO2013160335A3 Antigens and antigen combinations |
| 04/10/2014 | WO2013132485A9 Polymers having therapeutically active agents conjugated thereto, processes of preparing same and uses thereof |
| 04/10/2014 | WO2012135646A3 Proteases for degrading gluten |
| 04/10/2014 | WO2012099999A3 Methods and compositions for inducing weight loss |
| 04/10/2014 | WO2012088220A3 Expression of thrombin variants |
| 04/10/2014 | WO2012083092A3 Bi-dentate compounds as kinase inhibitors |
| 04/10/2014 | WO2012078850A3 Hemoglobin compositions and methods of use |
| 04/10/2014 | WO2012074989A3 Compositions and methods for the treatment of nervous disorders associated with diabetes |
| 04/10/2014 | WO2012058479A3 Method of improving transplant function using soluble complement receptor type i (scr1) |
| 04/10/2014 | US20140100666 Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures |
| 04/10/2014 | US20140100537 Transdermal pharmaceutical preparation and administration of tirofiban |
| 04/10/2014 | US20140100265 Gene Delivery Vehicles in the Treatment of Neurodegenerative Diseases |
| 04/10/2014 | US20140100261 Trpm-2 antisense therapy |
| 04/10/2014 | US20140100166 Methods for the prevention or treatment of heart failure |
| 04/10/2014 | US20140100165 Prevention of kidney injury or disease |
| 04/10/2014 | US20140100163 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
| 04/10/2014 | US20140100162 Prevention of kidney injury disease |
| 04/10/2014 | US20140100161 System and Method for Multiphasic Release of Growth Factors |
| 04/10/2014 | US20140100160 Novel use of c-terminal domain of igfbp-5 comprising heparin-binding domain as an angiogenesis inhibitor |
| 04/10/2014 | US20140100159 Use of relaxin to restore maternal physiology in pregnancies conveived by assisted reproductive technologies |
| 04/10/2014 | US20140100158 Use of Ultrarapid Acting Insulin |
| 04/10/2014 | US20140100157 Method of inhibiting clostridium difficile by administration of oritavancin |
| 04/10/2014 | US20140100156 Exendin-4 derivatives as dual glp1/glucagon agonists |
| 04/10/2014 | US20140100155 Combination therapy and kit for the prevention and treatment of cystic fibrosis |